Mary Beth Fortugno represents healthcare providers in a variety of industry sectors including four of the nation’s leading hospital companies and specialty pharmacies. She focuses her practice on transactions, managed care contracting, healthcare regulatory matters, operations and investigations. Having managed matters ranging from licensure diligence and new applications to major transactions and fraud and abuse investigations, Mary Beth has built a reputation within the industry for her knowledge and operational guidance. As former operations counsel to IASIS Healthcare, an acute-care hospital company, she brings first-hand experience to healthcare clients.
Mary Beth helps clients find solutions to complex regulatory, contracting, operational and transactional issues. Her practice involves:
American Bar Association
American Health Lawyers Association (AHLA) — Hospitals and Health Systems Practice Group, Chair (2015-2017), Vice Chair Education (2014-2015)
Harry Phillips American Inn of Court
We represented BioScrip, Inc. in its merger with Option Care Enterprises, Inc. The newly combined company, Option Care Health, Inc., emerges as the largest independent home and alternate site infusion services provider in the United States. Option Care Health’s common stock will be listed on the Nasdaq Global Select Market under the ticker symbol BIOS.
Represented Consonance Capital Partners in the recapitalization of Orsini Pharmaceutical Services, LLC
Represented CHS in its sale of Gulf Oaks Behavioral Hospital
Represented Community Pharmacy Partners in its investment by Altaris Capital Partners, LLC.
Represented Envision Healthcare in its definitive agreement to sell to KKR for $9.9 billion
Represented Lincare Holdings Inc. in its acquisition of Specialized Medical Services from The Riverside Company
Served as lead healthcare regulatory counsel to Ardent Health Services in its acquisition of East Texas Medical Center Regional Healthcare System (ETMC)
Represented Envision Healthcare (NYSE: EVHC) in its definitive agreement to sell American Medical Response (AMR) to KKR’s portfolio company, Air Medical Group Holdings (AMGH) for $2.4 billion
Served as healthcare regulatory counsel in the company’s merger with LHP Hospital Group
Chambers USA — Healthcare, Recognized Practitioner (2015-2017)
The Best Lawyers in America© — Health Care Law (2013-2020)
Journal of Transnational Law — Associate Editor
Vanderbilt Scholastic Excellence Award — Administrative Law; Federal Tax; Professional Responsibility